What is Genmab’s relationship to Medarex, Inc. and GenPharm International, Inc.?
Genmab has a unique alliance with Medarex, Inc. that gives Genmab access to Medarex’s proprietary human antibody technologies. Genmab exchanged stock for technology access at the time of the company’s founding. Genmab received the rights to develop 16 products with no further payments to Medarex. After these 16 licenses are used, Genmab can access fee based licenses for which it would owe royalties and milestones. Under the alliance, Genmab can develop an unlimited number of products for an unlimited period of time using the transgenic technology.
